Fate Therapeutics, Inc. (FATE)
1.28
-0.06
(-4.48%)
USD |
NASDAQ |
Nov 13, 16:00
1.275
0.00 (0.00%)
After-Hours: 19:59
Fate Therapeutics Total Liabilities (Quarterly) : 105.24M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 105.24M |
| June 30, 2026 | 106.66M |
| March 31, 2026 | 105.21M |
| December 31, 2025 | 111.75M |
| September 30, 2025 | 109.60M |
| June 30, 2025 | 110.27M |
| March 31, 2025 | 110.26M |
| December 31, 2024 | 121.97M |
| September 30, 2024 | 132.64M |
| June 30, 2024 | 131.84M |
| March 31, 2024 | 143.78M |
| December 31, 2023 | 137.80M |
| September 30, 2023 | 141.01M |
| June 30, 2023 | 147.00M |
| March 31, 2023 | 152.86M |
| December 31, 2022 | 221.62M |
| September 30, 2022 | 231.35M |
| June 30, 2022 | 226.58M |
| March 31, 2022 | 224.99M |
| December 31, 2021 | 242.62M |
| September 30, 2021 | 254.24M |
| June 30, 2021 | 263.60M |
| March 31, 2021 | 255.87M |
| December 31, 2020 | 238.01M |
| September 30, 2020 | 202.08M |
| Date | Value |
|---|---|
| June 30, 2020 | 179.48M |
| March 31, 2020 | 102.67M |
| December 31, 2019 | 57.52M |
| September 30, 2019 | 72.16M |
| June 30, 2019 | 72.35M |
| March 31, 2019 | 75.03M |
| December 31, 2018 | 52.56M |
| September 30, 2018 | 46.02M |
| June 30, 2018 | 31.33M |
| March 31, 2018 | 28.42M |
| December 31, 2017 | 28.10M |
| September 30, 2017 | 26.93M |
| June 30, 2017 | 18.74M |
| March 31, 2017 | 21.47M |
| December 31, 2016 | 21.89M |
| September 30, 2016 | 23.92M |
| June 30, 2016 | 26.05M |
| March 31, 2016 | 27.98M |
| December 31, 2015 | 29.92M |
| September 30, 2015 | 31.41M |
| June 30, 2015 | 32.41M |
| March 31, 2015 | 23.24M |
| December 31, 2014 | 22.86M |
| September 30, 2014 | 13.43M |
| June 30, 2014 | 3.913M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AVITA Medical, Inc. | 77.83M |
| Agenus, Inc. | 357.70M |
| Amgen, Inc. | 81.70B |
| Anika Therapeutics, Inc. | 52.02M |
| BioCryst Pharmaceuticals, Inc. | 988.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 238.28M |
| Shareholders Equity (Quarterly) | 133.03M |
| Debt to Equity Ratio | 0.56 |
| Current Ratio | 4.413 |
| Net Debt Paydown Yield | 0.47% |